Literature DB >> 21059878

Differential regulation of kidney and spleen cytokine responses in mice challenged with pathology-standardized doses of Candida albicans mannosylation mutants.

Luis Castillo1, Donna M MacCallum, Alistair J P Brown, Neil A R Gow, Frank C Odds.   

Abstract

Cell surface polysaccharides are key determinants of host responses to fungal infection. We determined the effects of alterations in Candida albicans cell surface polysaccharide composition and gross changes in the host immune response in groups of mice challenged intravenously with five C. albicans strains at doses adjusted to give equal disease progression 3 days later. The five strains used were the parental strain NGY152, two mutants with defective cell wall mannosylation, pmr1Δ mutant and mnt1/2Δ mutant, and the same two strains with a copy of PMR1 and MNT1 reintegrated, respectively. Renal and spleen levels of chemokines and cytokines previously shown to be key components of early host response to C. albicans were determined at intervals up to 3 days after challenge. By 12 h after C. albicans challenge, the levels of granulocyte colony-stimulating factor (G-CSF), keratinocyte-derived chemokine (KC), interleukin 6 (IL-6), monocyte chemotactic peptide 1 (MCP-1), macrophage inflammatory protein 1α (MIP-1α), MIP-1β, and MIP-2 were higher in the kidneys of mice challenged with the pmr1Δ mutant than in animals challenged with the other strains and were lower by day 3, suggesting an earlier host response to the pmr1Δ mutant. The production of these chemokines also diminished earlier than controls in mice infected with the mnt1/2Δ strain. Although these differences were statistically significant, their magnitude was seldom great, and no unambiguous evidence was obtained for individual responses specific to any cell surface glycosylation change. We conclude that complex, multifactorial local responses offset and obscure any differences resulting from differences in surface mannosylation of C. albicans strains when infection results from pathology-standardized challenges.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21059878      PMCID: PMC3019922          DOI: 10.1128/IAI.01004-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

Review 1.  Chemokines and their receptors: drug targets in immunity and inflammation.

Authors:  Antonella Viola; Andrew D Luster
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

Review 2.  An integrated model of the recognition of Candida albicans by the innate immune system.

Authors:  Mihai G Netea; Gordon D Brown; Bart Jan Kullberg; Neil A R Gow
Journal:  Nat Rev Microbiol       Date:  2008-01       Impact factor: 60.633

Review 3.  Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies.

Authors:  Stephan Segerer; Peter J Nelson; Detlef Schlöndorff
Journal:  J Am Soc Nephrol       Date:  2000-01       Impact factor: 10.121

4.  Candida albicans Pmr1p, a secretory pathway P-type Ca2+/Mn2+-ATPase, is required for glycosylation and virulence.

Authors:  Steven Bates; Donna M MacCallum; Gwyneth Bertram; Carol A Munro; H Bleddyn Hughes; Ed T Buurman; Alistair J P Brown; Frank C Odds; Neil A R Gow
Journal:  J Biol Chem       Date:  2005-04-20       Impact factor: 5.157

5.  Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells.

Authors:  Naotake Tsuboi; Yasunobu Yoshikai; Seiichi Matsuo; Takeshi Kikuchi; Ken-Ichiro Iwami; Yoshiyuki Nagai; Osamu Takeuchi; Shizuo Akira; Tetsuya Matsuguchi
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

6.  Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection.

Authors:  Donna M MacCallum; Alix Coste; Françoise Ischer; Mette D Jacobsen; Frank C Odds; Dominique Sanglard
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

7.  Saccharomyces cerevisiae- and Candida albicans-derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14- and Toll-like receptor 4-dependent manner.

Authors:  Hiroyuki Tada; Eiji Nemoto; Hidetoshi Shimauchi; Toshihiko Watanabe; Takeshi Mikami; Tatsuji Matsumoto; Naohito Ohno; Hiroshi Tamura; Ken-ichiro Shibata; Sachiko Akashi; Kensuke Miyake; Shunji Sugawara; Haruhiko Takada
Journal:  Microbiol Immunol       Date:  2002       Impact factor: 1.955

8.  Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors.

Authors:  Mihai G Netea; Neil A R Gow; Carol A Munro; Steven Bates; Claire Collins; Gerben Ferwerda; Richard P Hobson; Gwyneth Bertram; H Bleddyn Hughes; Trees Jansen; Liesbeth Jacobs; Ed T Buurman; Karlijn Gijzen; David L Williams; Ruurd Torensma; Alistair McKinnon; Donna M MacCallum; Frank C Odds; Jos W M Van der Meer; Alistair J P Brown; Bart Jan Kullberg
Journal:  J Clin Invest       Date:  2006-05-18       Impact factor: 14.808

9.  Massive induction of innate immune response to Candida albicans in the kidney in a murine intravenous challenge model.

Authors:  Donna M MacCallum
Journal:  FEMS Yeast Res       Date:  2009-10       Impact factor: 2.796

10.  Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus.

Authors:  Alexandra Brand; Donna M MacCallum; Alistair J P Brown; Neil A R Gow; Frank C Odds
Journal:  Eukaryot Cell       Date:  2004-08
View more
  7 in total

Review 1.  Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework.

Authors:  Mary Ann Jabra-Rizk; Eric F Kong; Christina Tsui; M Hong Nguyen; Cornelius J Clancy; Paul L Fidel; Mairi Noverr
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

2.  Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo.

Authors:  Keunsook K Lee; Donna M Maccallum; Mette D Jacobsen; Louise A Walker; Frank C Odds; Neil A R Gow; Carol A Munro
Journal:  Antimicrob Agents Chemother       Date:  2011-10-10       Impact factor: 5.191

3.  Role of Candida albicans secreted aspartyl protease Sap9 in interkingdom biofilm formation.

Authors:  Lindsay C Dutton; Howard F Jenkinson; Richard J Lamont; Angela H Nobbs
Journal:  Pathog Dis       Date:  2016-01-14       Impact factor: 3.166

4.  Investigation of OCH1 in the Virulence of Candida parapsilosis Using a New Neonatal Mouse Model.

Authors:  Katalin Csonka; Máté Vadovics; Annamária Marton; Csaba Vágvölgyi; Erik Zajta; Adél Tóth; Renáta Tóth; Csaba Vizler; László Tiszlavicz; Héctor M Mora-Montes; Attila Gácser
Journal:  Front Microbiol       Date:  2017-06-30       Impact factor: 5.640

5.  Specific Human and Candida Cellular Interactions Lead to Controlled or Persistent Infection Outcomes during Granuloma-Like Formation.

Authors:  Barbara Misme-Aucouturier; Marjorie Albassier; Nidia Alvarez-Rueda; Patrice Le Pape
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

6.  A novel renal epithelial cell in vitro assay to assess Candida albicans virulence.

Authors:  Edina K Szabo; Donna M Maccallum
Journal:  Virulence       Date:  2013-11-13       Impact factor: 5.882

7.  O-mannosylation in Candida albicans enables development of interkingdom biofilm communities.

Authors:  Lindsay C Dutton; Angela H Nobbs; Katy Jepson; Mark A Jepson; M Margaret Vickerman; Sami Aqeel Alawfi; Carol A Munro; Richard J Lamont; Howard F Jenkinson
Journal:  mBio       Date:  2014-04-15       Impact factor: 7.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.